Skip to content
November 6, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
FDA Expands Treatment Horizon for HER2-Positive Metastatic Breast Cancer: The Rise of Tucatinib Maintenance Therapy Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo
  • Patient Advocacy and Support

FDA Expands Treatment Horizon for HER2-Positive Metastatic Breast Cancer: The Rise of Tucatinib Maintenance Therapy

Dwi Wanna October 11, 2026
The landscape of oncology is undergoing a transformative shift as the U.S. Food and Drug Administration (FDA)...
Read More Read more about FDA Expands Treatment Horizon for HER2-Positive Metastatic Breast Cancer: The Rise of Tucatinib Maintenance Therapy
Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026 navigating-the-new-normal-breast-cancer-canada-announces-comprehensive-survivorship-webinar-series-for-october-2026
  • Patient Advocacy and Support

Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026

Dwi Wanna October 11, 2026
TORONTO, ON — As the medical community continues to make strides in early detection and acute treatment...
Read More Read more about Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026
Jordan’s Role as a Beacon of Humanitarian Health: A High-Level WHO State Visit jordans-role-as-a-beacon-of-humanitarian-health-a-high-level-who-state-visit-1
  • Breast Cancer Prevention and Lifestyle

Jordan’s Role as a Beacon of Humanitarian Health: A High-Level WHO State Visit

Pevita Pearce October 11, 2026
Executive Summary: A Strategic Partnership for Global Health The Director-General of the World Health Organization (WHO), Dr....
Read More Read more about Jordan’s Role as a Beacon of Humanitarian Health: A High-Level WHO State Visit
Biotech Industry Pulse: Market Volatility, Regulatory Shifts, and Strategic Capital Moves biotech-industry-pulse-market-volatility-regulatory-shifts-and-strategic-capital-moves-1
  • Treatment Innovations

Biotech Industry Pulse: Market Volatility, Regulatory Shifts, and Strategic Capital Moves

Layla Zulfa October 11, 2026
The biotechnology sector is currently navigating a period of intense scrutiny and rapid evolution. From the reassessment...
Read More Read more about Biotech Industry Pulse: Market Volatility, Regulatory Shifts, and Strategic Capital Moves
Patent War in Electrophysiology: Boston Scientific Targets J&J Subsidiary Over Hotwire Device patent-war-in-electrophysiology-boston-scientific-targets-jj-subsidiary-over-hotwire-device
  • Treatment Innovations

Patent War in Electrophysiology: Boston Scientific Targets J&J Subsidiary Over Hotwire Device

Suro Senen October 11, 2026
The high-stakes world of cardiac electrophysiology has entered a new phase of legal turbulence as Boston Scientific...
Read More Read more about Patent War in Electrophysiology: Boston Scientific Targets J&J Subsidiary Over Hotwire Device
The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research the-digital-renaissance-of-pathology-mining-archives-to-redefine-preclinical-research-8
  • Treatment Innovations

The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

Raul Delapena Setiawan October 11, 2026
In the landscape of modern drug discovery, the traditional animal study has long been viewed as a...
Read More Read more about The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research
A New Dawn for Reproductive Medicine: Mitochondrial Donation Breaks the Cycle of Inherited Disease a-new-dawn-for-reproductive-medicine-mitochondrial-donation-breaks-the-cycle-of-inherited-disease-3
  • Genomics and Precision Medicine

A New Dawn for Reproductive Medicine: Mitochondrial Donation Breaks the Cycle of Inherited Disease

Ali Ikhwan October 11, 2026
In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...
Read More Read more about A New Dawn for Reproductive Medicine: Mitochondrial Donation Breaks the Cycle of Inherited Disease
Deciphering the Biology of Silence: Dr. Samah Ahmed Unveils the Genetic Architecture of Age-Related Hearing Loss deciphering-the-biology-of-silence-dr-samah-ahmed-unveils-the-genetic-architecture-of-age-related-hearing-loss
  • Genomics and Precision Medicine

Deciphering the Biology of Silence: Dr. Samah Ahmed Unveils the Genetic Architecture of Age-Related Hearing Loss

Neng Nana October 11, 2026
In the complex landscape of human aging, few conditions are as pervasive—or as frequently misunderstood—as age-related hearing...
Read More Read more about Deciphering the Biology of Silence: Dr. Samah Ahmed Unveils the Genetic Architecture of Age-Related Hearing Loss
Rethinking Oxygen: A New Frontier in Treating Neurodegenerative Diseases rethinking-oxygen-a-new-frontier-in-treating-neurodegenerative-diseases
  • Genomics and Precision Medicine

Rethinking Oxygen: A New Frontier in Treating Neurodegenerative Diseases

Evan Lee Salim October 11, 2026
In a paradigm-shifting study that challenges conventional wisdom regarding cellular respiration, researchers at the Broad Institute of...
Read More Read more about Rethinking Oxygen: A New Frontier in Treating Neurodegenerative Diseases
Fueling the Future: HudsonAlpha Launches ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem fueling-the-future-hudsonalpha-launches-the-primer-lab-to-supercharge-alabamas-biotech-ecosystem-1
  • Genomics and Precision Medicine

Fueling the Future: HudsonAlpha Launches ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem

Siti Muinah October 11, 2026
HUNTSVILLE, AL – In a strategic move designed to cement Alabama’s status as a burgeoning global powerhouse...
Read More Read more about Fueling the Future: HudsonAlpha Launches ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem

Posts pagination

Previous 1 … 129 130 131 132 133 134 135 … 862 Next

Recent Posts

  • Groundbreaking St. Jude Study Reveals Genetic Predisposition as Major Driver of Secondary Cancers in Childhood Survivors, Reshaping Future Care
  • Edwards Lifesciences Raises 2026 Outlook Following Robust Q3 Performance
  • The Age of the Autonomous Trial: Navigating the Human-Agent Frontier in Clinical Research
  • The Frontier of Genetic Medicine: Decoding the ‘In Vivo’ vs. ‘Ex Vivo’ Divide
  • Decoding the Immune Frontier: New Insights into Genetic Diversity and Malaria Resistance

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

groundbreaking-st-jude-study-reveals-genetic-predisposition-as-major-driver-of-secondary-cancers-in-childhood-survivors-reshaping-future-care
  • Medical Research and Clinical Trials

Groundbreaking St. Jude Study Reveals Genetic Predisposition as Major Driver of Secondary Cancers in Childhood Survivors, Reshaping Future Care

Asep Darmawan November 5, 2026
edwards-lifesciences-raises-2026-outlook-following-robust-q3-performance
  • Treatment Innovations

Edwards Lifesciences Raises 2026 Outlook Following Robust Q3 Performance

Lina Hope November 5, 2026
the-age-of-the-autonomous-trial-navigating-the-human-agent-frontier-in-clinical-research
  • Treatment Innovations

The Age of the Autonomous Trial: Navigating the Human-Agent Frontier in Clinical Research

Nana Wu November 5, 2026
the-frontier-of-genetic-medicine-decoding-the-in-vivo-vs-ex-vivo-divide
  • Genomics and Precision Medicine

The Frontier of Genetic Medicine: Decoding the ‘In Vivo’ vs. ‘Ex Vivo’ Divide

Raul Delapena Setiawan November 5, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.